Clinical Trial Update: Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa [Phase 1]

View source ↗

Summary

Phase 1 pilot study update for ELK-003 Eye Drops to treat ocular manifestations of epidermolysis bullosa, currently active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa
• Epidermolysis Bullosa
• Junctional Epidermolysis Bullosa
• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• ELK-003 Eye Drops (ELK-003)

Snippet

Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal | Conditions: Junctional Epidermolysis Bullosa, Epidermolysis Bullosa (EB) | Phase 1 | Status: ACTIVE_NOT_RECRUITING